Ureteral Metastasis From Prostate Cancer: A Report of Two Cases
cll prognosis :: Article Creator Chemotherapy Regimens Remain Most Common First-Line Treatment For CLL The use of targeted therapies for chronic lymphocytic leukemia (CLL) has increased over time, but chemotherapy regimens remain the most common first-line treatment for CLL, according to research published in HemaSphere. The researchers noted that BTK and BCL2 inhibitors, alone or as part of combination regimens, have proven superior to chemoimmunotherapy in the first-line and relapsed/refractory settings, but the targeted agents are rarely used as first-line therapy. They are becoming more common in the second line and later, however. The researchers conducted this study to evaluate real-world treatment patterns for patients with CLL in 25 countries. The study included 7382 patients — 7134 with CLL and 248 with small lymphocytic lymphoma. The patients had received first-line treatment between 2000 and 2016. The median patient age was 64 years a...